中国全科医学2026，Vol.29Issue(19)：2593-2607,15.DOI:10.12114/j.issn.1007-9572.2026.0063
酸相关疾病药物治疗专家共识
Expert Consensus on Medication Therapy for Acid-related Diseases
摘要
Abstract
Acid-related diseases are characterized by high incidence rates and significant disease burden.Excessive gastric acid secretion or heightened gastric acid sensitivity represents the common pathogenesis of these conditions,leading to the widespread application of the principle of"treating different diseases with the same therapy"in medication management.With growing concerns regarding the risks associated with inappropriate use of acid-suppressing drugs such as proton pump inhibitors,there is an urgent need to deepen the systematic understanding of medication therapy for acid-related diseases and to promote rational drug use.This consensus was developed by a multidisciplinary panel of experts in clinical medicine,pharmacy,and methodology.Based on evidence-based medicine,it provides a systematic elaboration on the classification of acid-related diseases,therapeutic drugs,diagnostic methods,and pharmaceutical care services.Additionally,it offers consensus recommendations and management strategies for key clinical issues encountered in practice.The release of this consensus is of great significance for establishing a medication therapy management system and promoting rational drug use for acid-related diseases.关键词
酸相关疾病/药学服务/药学治疗/合理用药/专家共识Key words
Acid-related diseases/Pharmaceutical services/Medication therapy/Rational drug use/Expert consensus分类
医药卫生引用本文复制引用
中国药理学会药源性疾病专委会,胡幼红..酸相关疾病药物治疗专家共识[J].中国全科医学,2026,29(19):2593-2607,15.基金项目
国家卫生健康委医药卫生科技发展中心"创新药物上市后临床研究科研专项"2024年度面上课题(WKZX2024CX501221) （WKZX2024CX501221）
